| Temporal development of the gut microbiome in early childhood from the TEDDY study CJ Stewart, NJ Ajami, JL O’Brien, DS Hutchinson, DP Smith, MC Wong, ... Nature 562 (7728), 583-588, 2018 | 1641 | 2018 |
| Efficacy and safety of sirolimus in lymphangioleiomyomatosis FX McCormack, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ... New England Journal of Medicine 364 (17), 1595-1606, 2011 | 1178 | 2011 |
| Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association RA Insel, JL Dunne, MA Atkinson, JL Chiang, D Dabelea, PA Gottlieb, ... Diabetes care 38 (10), 1964-1974, 2015 | 1120 | 2015 |
| BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases T Pal, J Permuth‐Wey, JA Betts, JP Krischer, J Fiorica, H Arango, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 960 | 2005 |
| Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors PK Duffner, ME Horowitz, JP Krischer, HS Friedman, PC Burger, ... New England Journal of Medicine 328 (24), 1725-1731, 1993 | 953 | 1993 |
| Effects of insulin in relatives of patients with type 1 diabetes mellitus Diabetes Prevention Trial–Type 1 Diabetes Study Group New England Journal of Medicine 346 (22), 1685-1691, 2002 | 911 | 2002 |
| An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes KC Herold, BN Bundy, SA Long, JA Bluestone, LA DiMeglio, MJ Dufort, ... New England Journal of Medicine 381 (7), 603-613, 2019 | 857 | 2019 |
| The human gut microbiome in early-onset type 1 diabetes from the TEDDY study T Vatanen, EA Franzosa, R Schwager, S Tripathi, TD Arthur, K Vehik, ... Nature 562 (7728), 589-594, 2018 | 761 | 2018 |
| Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1 JS Skyler, JP Krischer, J Wolfsdorf, C Cowie Diabetes care 28 (5), 1068, 2005 | 761 | 2005 |
| Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. JP Krischer, S Epstein, DD Cuthbertson, AM Goorin, ML Epstein, ... Journal of clinical oncology 15 (4), 1544-1552, 1997 | 636 | 1997 |
| Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 378 (9789), 412-419, 2011 | 615 | 2011 |
| Effects of health insurance and race on early detection of cancer RG Roetzheim, N Pal, C Tennant, L Voti, JZ Ayanian, A Schwabe, ... Journal of the National Cancer Institute 91 (16), 1409-1415, 1999 | 583 | 1999 |
| Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan Y Inoue, BC Trapnell, R Tazawa, T Arai, T Takada, N Hizawa, Y Kasahara, ... American journal of respiratory and critical care medicine 177 (7), 752-762, 2008 | 542 | 2008 |
| Complications of cardiac resuscitation JP Krischer, EG Fine, JH Davis, EL Nagel Chest 92 (2), 287-291, 1987 | 516 | 1987 |
| The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study JP Krischer, KF Lynch, DA Schatz, J Ilonen, Å Lernmark, WA Hagopian, ... Diabetologia 58, 980-987, 2015 | 481 | 2015 |
| Lysophospholipids are potential biomarkers of ovarian cancer R Sutphen, Y Xu, GD Wilbanks, J Fiorica, EC Grendys Jr, JP LaPolla, ... Cancer Epidemiology Biomarkers & Prevention 13 (7), 1185-1191, 2004 | 472 | 2004 |
| Clinical research for rare disease: opportunities, challenges, and solutions RC Griggs, M Batshaw, M Dunkle, R Gopal-Srivastava, E Kaye, J Krischer, ... Molecular genetics and metabolism 96 (1), 20-26, 2009 | 432 | 2009 |
| A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes WJ Riley, NK Maclaren, J Krischer, RP Spillar, JH Silverstein, DA Schatz, ... New England journal of medicine 323 (17), 1167-1172, 1990 | 431 | 1990 |
| International cooperation to enable the diagnosis of all rare genetic diseases KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, ... The American Journal of Human Genetics 100 (5), 695-705, 2017 | 407 | 2017 |
| Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial DK Wherrett, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 378 (9788), 319-327, 2011 | 407 | 2011 |
